INTANGIBLE ASSETS AND GOODWILL (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2021 |
Jun. 30, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Apr. 15, 2021 |
|
| Notes to Financial Statements [Line Items] | |||||
| Finite-Lived Intangible Asset, Useful Life | 15 years | ||||
| Amortization of intangible assets | $ 216,000 | $ 95,000 | $ 305,000 | $ 156,000 | |
| Goodwill | 1,355,077 | 1,355,077 | $ 1,355,077 | ||
| Trade Name | $ 90,000 | $ 90,000 | |||
| Agribody Technologies, Inc [Member] | |||||
| Notes to Financial Statements [Line Items] | |||||
| Finite-Lived Intangible Asset, Useful Life | 20 years | ||||
| Finite-lived Intangible Assets Acquired | $ 3,200,000 | ||||
| X | ||||||||||
- Definition Notes to Financial Statements. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|